MedPath

Frequency of Complete Pathological Response in axilla of breast cancer patients after Neoadjuvant systemic therapy. A cross sectional study

Conditions
BREASTCANCER
C50
Malignant neoplasm of breast
Registration Number
DRKS00026717
Lead Sponsor
Aga Khan Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
326
Inclusion Criteria

1- All patients aged above 18
2- Patients with Diagnosed Breast cancer.
3- Patients who achieved complete pathological response after neoadjuvant Chemotherapy.

Exclusion Criteria

1. Patients who got operated outside Aga Khan University Hospital
2. Patients whose specimen histopathology was reported from elsewhere.
3. Patients with incomplete medical records

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Frequency of Complete Pathological Response in axilla after NACT
Secondary Outcome Measures
NameTimeMethod
type of Tumor biology which achieve maximum complete pathological response
© Copyright 2025. All Rights Reserved by MedPath